Clinical and pathological factors and outcome of central nervous system metastasis in breast cancer
BackgroundIn Switzerland, approximately 6000 new breast cancer cases and 1300 deaths are reported annually. Brain metastasis from breast cancer (BMBC) has a major effect on prognosis. This study aimed to identify prognostic factors for overall survival (OS) in a cohort of Swiss patients with BMBC. T...
Main Authors: | Dimitri Dettwiler, Elena-Diana Chiru, Eveline Daetwyler, Vérène Dougoud-Chauvin, Markus W. Gross, Christian Kurzeder, Alfred Zippelius, Andreas Schötzau, Marcus Vetter |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1247402/full |
Similar Items
-
Advances in the Management of Central Nervous System Metastases from Breast Cancer
by: Jorge Avila, et al.
Published: (2022-10-01) -
Upfront Taxane Could Be Superior to Pegylated Liposomal Doxorubicin (PLD): A Retrospective Real-World Analysis of Treatment Sequence Taxane–PLD versus PLD–Taxane in Patients with Metastatic Breast Cancer
by: Till Wallrabenstein, et al.
Published: (2023-10-01) -
Bone targeted therapies in advanced breast cancer
by: Ewelina Biskup, et al.
Published: (2017-06-01) -
Prognostic Factors in Breast Cancer Patients with Brain Metastases: Retrospective Analysis
by: Ramy Ghali, et al.
Published: (2018-12-01) -
Incidence of central nervous system metastases in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with trastuzumab: A meta-analysis
by: Xue Bai, et al.
Published: (2021-08-01)